Trevena Inc
Biotechnology
Healthcare
TRVN
1.00 M shares
NASDAQ US
traded
09 Apr 2025
listed
no
open
1.38
52 week high
14.50
high
1.38
52 week low
1.32
low
1.30
growth
-86.96 %
previous Close
1.32
P/E ratio
-0
market cap
1.46 M
div yield
0
usd
Sep 2024
qoq
revenue
283 K
-12.92 %
net incoming
-4.94 M
-0.98 %
eps
-5.79 %
-0.70 %
eps surprise
20.90 %
net profit margin
-1745.23 %
-240.00 %
operating incoming
-5.58 M
14.24 %
net change in cash
-2.28 M
68.23 %
cash on hand
13.46 M
-17.75 %
cost of revenue
114 K
-40.63 %
top top